Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / Q•••••• C••••••

Q•••••• C••••••

CandidateMiddle marketSingaporeq•••••••••.comSEC exempt reporting adviser

Discover Q•••••• C••••••, a top private equity firm in India and Singapore, dedicated to advancing healthcare through impactful investments and innovative solutions.

Classification
Class
Candidatecandidate, confidence 40%
Basis
R7: admitted on 10 Private Equity Fund(s) among 34 vehicles; no rule fired
Size band
Middle marketdefined by: proxy: $1.74bn Private Equity Fund GAV on the Form ADV filed 2024-03-28
Classification history (1)
  1. Sep 13, 2026
    Candidate (candidate, 40%, cls-pe-1)
    R7: admitted on 10 Private Equity Fund(s) among 34 vehicles; no rule fired
Regulatory footprint (Form ADV)
Adviser type
exempt reporting adviser
Form ADV filings
Jul 29, 2015 to Mar 28, 2024
RAUM
unknownregulatory assets under management of the adviser; not dry powder, not a fund size
PE funds, latest filing
10
PE fund GAV, latest filing
$1.7Breported gross assets (Form ADV), not fund size
All private fund GAV
$2.9Bevery private fund type, latest filing
2024 PE fund GAV
$1.7Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
PE share of funds, lifetime
29%
Fund type mix
filed 2024-03-28, latest gav Other Private Fund $1.1B, Private Equity Fund $1.7B, latest counts Other Private Fund 23, Private Equity Fund 10, lifetime distinct Other Private Fund 24, Private Equity Fund 10
Employees
unknown
Headquarters
Singapore, Singapore
Office address
11A STANLEY STREET, Singapore, 068730
Business phone
6598195606
Stated criteria beside observed behaviour
8 observed deals
Stated by the firm
Sectors
healthcare, life sciences, industrials, technology, media telecom, consumer
Geography
Southeast, Asia, United States, Europe, Global
Revenue
not stated or not yet read
EBITDA
not stated or not yet read
Enterprise value
not stated or not yet read
Equity check
not stated or not yet read
Control
not stated or not yet read
Thesis
We focus on partnering with large regional healthcare companies and, with our active investment strategy, help them grow into regional leaders.
Observed from deals on record
roles
unknown 8
period
to unknown, from unknown, undated holdings 8, dated observations 0
window
last unknown, first unknown
control
unknown 8
companies
8
geography
investments
8
seller kinds
transactions
0
cadence by year
platform add on
add ons 0, platforms 0, add ons per platform unknown
sector known for
0
disclosed value usd
n 0
sector distribution
holding period years
n 0
repeat counterparties
subsector distribution

8 companies on the graph (0 transactions); no dated observations

Funds
10 on record
FundVehicleVintageReported gross assets (Form ADV), not fund sizeGAV by yearForm D soldLifecycle
Q•••••• C•••••• F••• I•• L•
ADV: Private Equity Fund
buyout or unlabelled2024
first reported on Form ADV
$67.1M
as of Mar 28, 2024
no Form DUnknown
Q•••••• C•••••• F••• I•• H••••••• P•• L••
ADV: Private Equity Fund
buyout or unlabelled2024
first reported on Form ADV
$64.9M
as of Mar 28, 2024
no Form DUnknown
N••• O•••• I••••••••• H••••••• P•• L••
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$205M
as of Mar 28, 2024
no Form DUnknown
F•••• O•••• I••••••••• H••••••• P•• L••
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$197M
as of Mar 28, 2024
no Form DUnknown
Q•••••• C•••••• G•
ADV: Private Equity Fund
buyout or unlabelled2022
first reported on Form ADV
$7,764
as of Mar 28, 2024
no Form DEarly deployment
Q•••••• C•••••• F••• I• P•• L•
ADV: Private Equity Fund
buyout or unlabelled2020
first reported on Form ADV
$450M
as of Mar 28, 2024
no Form DActive deployment
Q•••••• C•••••• F••• I• H••••••• P•• L••
ADV: Private Equity Fund
buyout or unlabelled2020
first reported on Form ADV
$304M
as of Mar 28, 2024
no Form DSuccessor fundraising
Q•••••• C•••••• F••• I• L•
ADV: Private Equity Fund
buyout or unlabelled2020
first reported on Form ADV
$279M
as of Mar 28, 2024
no Form DActive deployment
Q•••••• C•••••• F••• I• G•
ADV: Private Equity Fund
buyout or unlabelled2019
first reported on Form ADV
$5,184
as of Mar 28, 2024
no Form DSuccessor fundraising
Q•••••• C•••••• F••• L•
ADV: Private Equity Fund
buyout or unlabelledunknown$175M
as of Mar 28, 2024
no Form DHarvest
Team
3 current, 1 former
Portfolio
8 relationships, 0 platforms, 0 add-ons
Transactions
0 on record
No transaction naming this firm has been collected yet. The deal tape is read from SEC filings and cited announcements.
Placement agents, lenders, advisers and co-investors
3 relationships
Placement agents (3)
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
2 most recent
  1. Mar 6, 2026
    Q•••••• C••••••: Private Equity Funds on Form ADV 10 (2024 extract) -> 3 (roster 2026-09-01)
  2. Jul 29, 2015
    Q•••••• C•••••• first filed Form ADV in the extract (ERA)